|
1
|
Liu Y and Cao X: The origin and function
of tumor-associated macrophages. Cell Mol Immunol. 12:1–4. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Biswas SK, Sica A and Lewis CE: Plasticity
of macrophage function during tumor progression: Regulation by
distinct molecular mechanisms. J Immunol. 180:2011–2017. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Biswas SK and Mantovani A: Macrophage
plasticity and interaction with lymphocyte subsets: Cancer as a
paradigm. Nat Immunol. 11:889–896. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
van Ravenswaay Claasen HH, Kluin PM and
Fleuren GJ: Tumor infiltrating cells in human cancer. On the
possible role of CD16+ macrophages in antitumor cytotoxicity. Lab
Invest. 67:166–174. 1992.PubMed/NCBI
|
|
5
|
Coussens LM and Werb Z: Inflammation and
cancer. Nature. 420:860–867. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Franklin RA, Liao W, Sarkar A, Kim MV,
Bivona MR, Liu K, Pamer EG and Li MO: The cellular and molecular
origin of tumor-associated macrophages. Science. 344:921–925. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Schultze JL, Schmieder A and Goerdt S:
Macrophage activation in human diseases. Semin Immunol. 27:249–256.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Sica A and Mantovani A: Macrophage
plasticity and polarization: In vivo veritas. J Clin Invest.
122:787–795. 2012. View
Article : Google Scholar : PubMed/NCBI
|
|
9
|
Martinez FO, Sica A, Mantovani A and
Locati M: Macrophage activation and polarization. Front Biosci.
13:453–461. 2008. View
Article : Google Scholar : PubMed/NCBI
|
|
10
|
Jeannin P, Paolini L, Adam C and Delneste
Y: The roles of CSFs on the functional polarization of
tumor-associated macrophages. FEBS J. 285:680–699. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Murdoch C, Muthana M and Lewis CE: Hypoxia
regulates macrophage functions in inflammation. J Immunol.
175:6257–6263. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Lewis C and Murdoch C: Macrophage
responses to hypoxia: Implications for tumor progression and
anti-cancer therapies. Am J Pathol. 167:627–635. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Roda JM, Wang Y, Sumner LA, Phillips GS,
Marsh CB and Eubank TD: Stabilization of HIF-2α induces sVEGFR-1
production from tumor-associated macrophages and decreases tumor
growth in a murine melanoma model. J Immunol. 189:3168–3177. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Burke B, Giannoudis A, Corke KP, Gill D,
Wells M, Ziegler-Heitbrock L and Lewis CE: Hypoxia-induced gene
expression in human macrophages: Implications for ischemic tissues
and hypoxia-regulated gene therapy. Am J Pathol. 163:1233–1243.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Lewis JS, Lee JA, Underwood JC, Harris AL
and Lewis CE: Macrophage responses to hypoxia: Relevance to disease
mechanisms. J Leukoc Biol. 66:889–900. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Huber R, Meier B, Otsuka A, Fenini G,
Satoh T, Gehrke S, Widmer D, Levesque MP, Mangana J, Kerl K, et al:
Tumour hypoxia promotes melanoma growth and metastasis via High
Mobility Group Box-1 and M2-like macrophages. Sci Rep. 6:299142016.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Didkowska J, Wojciechowska U, Manczuk M
and Łobaszewski J: Lung cancer epidemiology: Contemporary and
future challenges worldwide. Ann Transl Med. 4:1502016. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Dizon DS, Krilov L, Cohen E, Gangadhar T,
Ganz PA, Hensing TA, Hunger S, Krishnamurthi SS, Lassman AB,
Markham MJ, et al: Clinical cancer advances 2016: Annual report on
progress against cancer from the American Society of Clinical
Oncology. J Clin Oncol. 34:987–1011. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Ugel S, De Sanctis F, Mandruzzato S and
Bronte V: Tumor-induced myeloid deviation: When myeloid-derived
suppressor cells meet tumor-associated macrophages. J Clin Invest.
125:3365–3376. 2015. View
Article : Google Scholar : PubMed/NCBI
|
|
20
|
Quatromoni JG and Eruslanov E:
Tumor-associated macrophages: Function, phenotype, and link to
prognosis in human lung cancer. Am J Transl Res. 4:376–389.
2012.PubMed/NCBI
|
|
21
|
Meng X, Kong FM and Yu J: Implementation
of hypoxia measurement into lung cancer therapy. Lung Cancer.
75:146–150. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Karetsi E, Ioannou MG, Kerenidi T, Minas
M, Molyvdas PA, Gourgoulianis KI and Paraskeva E: Differential
expression of hypoxia-inducible factor 1α in non-small cell lung
cancer and small cell lung cancer. Clinics (Sao Paulo).
67:1373–1378. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Swinson DE, Jones JL, Cox G, Richardson D,
Harris AL and O'Byrne KJ: Hypoxia-inducible factor-1 alpha in non
small cell lung cancer: Relation to growth factor, protease and
apoptosis pathways. Int J Cancer. 111:43–50. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Chavez-Galan L, Olleros ML, Vesin D and
Garcia I: Much more than M1 and M2 macrophages, there are also
CD169(+) and TCR(+) macrophages. Front Immunol.
6:2632015.PubMed/NCBI
|
|
26
|
Roszer T: Understanding the mysterious M2
macrophage through activation markers and effector mechanisms.
Mediators Inflamm. 2015:8164602015. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Wan J, Ma J, Mei J and Shan G: The effects
of HIF-1alpha on gene expression profiles of NCI-H446 human small
cell lung cancer cells. J Exp Clin Cancer Res. 28:1502009.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Wan J, Chai H, Yu Z, Ge W, Kang N, Xia W
and Che Y: HIF-1α effects on angiogenic potential in human small
cell lung carcinoma. J Exp Clin Cancer Res. 30:772011. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Goldberg MA and Schneider TJ: Similarities
between the oxygen-sensing mechanisms regulating the expression of
vascular endothelial growth factor and erythropoietin. J Biol Chem.
269:4355–4359. 1994.PubMed/NCBI
|
|
30
|
Bachstetter AD and Van Eldik LJ: The p38
MAP kinase family as regulators of proinflammatory cytokine
production in degenerative diseases of the CNS. Aging Dis.
1:199–211. 2010.PubMed/NCBI
|
|
31
|
Xu L, Pathak PS and Fukumura D:
Hypoxia-induced activation of p38 mitogen-activated protein kinase
and phosphatidylinositol 3′-kinase signaling pathways contributes
to expression of interleukin 8 in human ovarian carcinoma cells.
Clin Cancer Res. 10:701–707. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Takeda N, O'Dea EL, Doedens A, Kim JW,
Weidemann A, Stockmann C, Asagiri M, Simon MC, Hoffmann A and
Johnson RS: Differential activation and antagonistic function of
HIF-{alpha} isoforms in macrophages are essential for NO
homeostasis. Genes Dev. 24:491–501. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Imtiyaz HZ, Williams EP, Hickey MM, Patel
SA, Durham AC, Yuan LJ, Hammond R, Gimotty PA, Keith B and Simon
MC: Hypoxia-inducible factor 2alpha regulates macrophage function
in mouse models of acute and tumor inflammation. J Clin Invest.
120:2699–2714. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Mosser DM and Edwards JP: Exploring the
full spectrum of macrophage activation. Nat Rev Immunol. 8:958–969.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Talks KL, Turley H, Gatter KC, Maxwell PH,
Pugh CW, Ratcliffe PJ and Harris AL: The expression and
distribution of the hypoxia-inducible factors HIF-1alpha and
HIF-2alpha in normal human tissues, cancers, and tumor-associated
macrophages. Am J Pathol. 157:411–421. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Brune B, Dehne N, Grossmann N, Jung M,
Namgaladze D, Schmid T, von Knethen A and Weigert A: Redox control
of inflammation in macrophages. Antioxid Redox Signal. 19:595–637.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Douglas NC, Zimmermann RC, Tan QK,
Sullivan-Pyke CS, Sauer MV, Kitajewski JK and Shawber CJ: VEGFR-1
blockade disrupts peri-implantation decidual angiogenesis and
macrophage recruitment. Vasc Cell. 6:162014. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Li N, Qin J, Lan L, Zhang H, Liu F, Wu Z,
Ni H and Wang Y: PTEN inhibits macrophage polarization from M1 to
M2 through CCL2 and VEGF-A reduction and NHERF-1 synergism. Cancer
Biol Ther. 16:297–306. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Almendros I, Gileles-Hillel A, Khalyfa A,
Wang Y, Zhang SX, Carreras A, Farré R and Gozal D: Adipose tissue
macrophage polarization by intermittent hypoxia in a mouse model of
OSA: Effect of tumor microenvironment. Cancer Lett. 361:233–239.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Fu S, Bai R, Zhao Z, Zhang Z, Zhang G,
Wang Y, Wang Y, Jiang D and Zhu D: Overexpression of
hypoxia-inducible factor-1α and vascular endothelial growth factor
in sacral giant cell tumors and the correlation with tumor
microvessel density. Exp Ther Med. 8:1453–1458. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Shologu N, Scully M, Laffey JG and O'Toole
D: Human mesenchymal stem cell secretome from bone marrow or
adipose-derived tissue sources for treatment of hypoxia-induced
pulmonary epithelial injury. Int J Mol Sci. 19(pii): E29962018.
View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Sakiyama S, dePerrot M, Han B, Waddell TK,
Keshavjee S and Liu M: Ischemia-reperfusion decreases protein
tyrosine phosphorylation and p38 mitogen-activated protein kinase
phosphorylation in rat lung transplants. J Heart Lung Transplant.
22:338–346. 2003. View Article : Google Scholar : PubMed/NCBI
|
